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1. Introduction 
Ribonucleotide reductase (RNR) activity is generally required to provide deoxyribonucleoside 
triphosphates (dNTPs or DNA-precursors) for DNA replication (Thelander and Reichard, 
1979). This property has made both RNR and the pathways RNR depends upon important 
drug-targets. For example, the drug hydroxyurea is a specific inhibitor of RNR and has been 
used for many decades as an effective chemotherapeutic agent for certain cancers and viral 
diseases (Navarra and Preziosi, 1999; Wright et al., 1990; Yarbro, 1992). This chapter focuses 
on two critical pathways that lie upstream of RNR and are important for supporting RNR 
activity: namely, the glutathione (GSH) pathway and the thioredoxin (Trx) pathway. These 
pathways were first uncovered in bacterial systems roughly fifty years ago. In the ensuing 
half-century, the components and activities of these pathways have been intensely studied 
in bacterial, archaebacterial, and eukaryotic systems, both in vivo and in vitro (Holmgren, 
1977; Holmgren, 1989). The GSH and Trx pathways, themselves, are ubiquitous in biology, 
yet various components of the pathways exhibit activities and, in some cases, evolutionary 
histories, that are particular to animal systems. Classic descriptive and biochemical studies 
laid the groundwork for understanding these pathways in animals; however, only in recent 
years have genetic systems been established in which the physiological activities of these 
pathways could be tested (Arner, 2009; Holmgren and Lu, 2010; Holmgren and Sengupta, 
2010). Here I will overview the Trx and GSH pathways and their contributions to DNA 
replication. Particular attention will be paid to recent revelations on the activities and 
properties of these systems in animals that differ from those in other biological systems. 
Some recent advances have come from the development of mouse models bearing targeted 
“conditional” alleles of the gene encoding thioredoxin reductase I (TrxR1, also called Txnrd1 
or TR1), which can be disrupted in a cell type- or developmental stage-specific manner. 
Whereas these models are yielding some exciting insights into the Trx and GSH systems in 
embryonic development, stress responses, toxicology, cancer, and other processes 
(Bondareva et al., 2007; Branco et al., 2011; Carvalho et al., 2008; Jakupoglu et al., 2005; 
Mandal et al., 2010; Rogers et al., 2004; Suvorova et al., 2009; Tipple et al., 2007; Zhang and 
Lu, 2007), the current treatise will emphasize the interplay of these pathways in supporting 
DNA replication in animal systems. The enormity of the body of literature on the Trx, GSH, 
and RNR systems precludes an exhaustive review of these materials, and it is my intention 
to cover these subjects in only a cursory manner to set the backdrop for understanding these 
systems in the context of DNA replication in animals. The reader is directed to more 
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complete recent reviews on these subjects (Arner, 2009; Holmgren and Sengupta, 2010; Lu 
and Holmgren, 2009). I apologize in advance for my oversights and omissions related to the 
many important studies that have led to the current status of the field.  
2. Thioredoxin reductase and glutathione reductase 
Thioredoxin reductases (TrxRs) are enzymes that use electrons from NADPH + H+ to restore 
the “active” reduced state of oxidized Trx (Fig. 1). Similarly, glutathione reductases (Gsrs) 
are enzymes that use electrons from NADPH + H+ to convert oxidized glutathione disulfide 
(GSSG) into two molecules of reduced GSH (Arner and Holmgren, 2000; Holmgren, 1980; 
Holmgren, 2000). In both cases, electrons are typically exchanged as a “reductive currency” 
by altering the redox state of protein- or small molecule-sulfur residues. In combination, 
these two pathways provide reducing potential to countless reactions in cellular, sub-
cellular and extracellular compartments, and constitute the predominant endogenous 
antioxidant system (Arner, 2009; Arner and Holmgren, 2006; Holmgren, 2000; Lillig and 
Holmgren, 2007; Nordberg and Arner, 2001). Trx and GSH serve as “electron-shuttles”, 
transporting this reducing potential to various enzymes and reactions. Both systems 
participate in homeostatic antioxidant activities, for example by providing electrons to either 
the GSH-dependent glutathione peroxidases (Gpxs) or the Trx-dependent peroxiredoxins 
(Prxs) that each contribute to detoxification of reactive oxygen species in cells  
 
 
 
 
Fig. 1. Cytosolic thioredoxin reductase cycle. Reducing potential arrives at TrxR1 in the form 
of NADPH and a proton. TrxR1 reduces disulfide-form Trx1 (oxidized) to the dithiol-form. 
Trx1 is a small protein that can transport this reducing potential to locations throughout the 
cell; however it does not enter or exchange reducing potential with mitochondria. Reduced 
Trx1 is a major protein-disulfide reductase and the immediate source of electrons for many 
enzymatic reactions, including RNR, Prxs, 3’-phosphoadenylylsulfate (PAPS) reductase, 
methionine sulfoxide reductases, and others. This results in oxidation of Trx1 to the 
disulfide form, which then cycles back through TrxR1 (Arner, 2009; Holmgren and 
Bjornstedt, 1995). 
www.intechopen.com
 
DNA Replication in Animal Systems Lacking Thioredoxin Reductase I 
 
567 
(Arner and Holmgren, 2000; Berndt et al., 2007; Carmel-Harel and Storz, 2000; Holmgren, 
2000). GSH can also reduce glutaredoxins (Grxs), which are small Trx-like proteins that 
further shuttle the electrons to various destinations, often but not always functioning 
analogous to Trxs (Fernandes and Holmgren, 2004; Holmgren, 1989; Holmgren, 2000; 
Holmgren et al., 2005; Meyer et al., 2009; Meyer et al., 2008). Although the Trx pathway and 
the GSH pathway are each most well known for somewhat different roles (Berndt et al., 
2008; Carmel-Harel and Storz, 2000; Hayes and Pulford, 1995; Holmgren, 2000), there is 
enormous overlap between the two pathways and, for the most part, general physiological 
equivalence of the two pathways. Some evidence suggests the Trx pathway can respond to 
cellular damage by activating the cytoprotective Nrf2 stress-response pathway, which, in 
turn, induces expression of the genes encoding components of both the Trx and the GSH 
systems (Arner, 2009; Ishii and Yanagawa, 2007; Itoh et al., 1999; Nguyen et al., 2009; 
Suvorova et al., 2009). Generally, either the GSH or the Trx pathway can complement 
deficiencies in the other, resulting in a robust combined reductive system (Arner, 2009; 
Holmgren, 2000).   
3. Activities and requirements of RNR 
The role of RNR in replication is to provide dNTPs for synthesis of a duplicate genome by 
DNA polymerase during S phase of the cell cycle (Fig. 2). This pathway, in which DNA-
precursors are made from endogenous RNA-precursors is termed the de novo biosynthesis 
pathway. Although salvage pathways can also provide a source of dNTPs using exogenous 
deoxyribonucleosides (Arner and Eriksson, 1995), sufficient exogenous sources of these 
substrates are rarely available. Thus, whereas salvage pathways might provide a sufficient 
source of DNA precursors for repair and perhaps for mitochondrial DNA replication, they 
generally will not support S phase genome replication (Iwasaki et al., 1997; Mathews and 
Song, 2007; Pontarin et al., 2007).  
RNR functions by reductive conversion of generally abundant RNA precursors, in the form 
of ribonucleoside diphosphates (rNDPs), into deoxyribonucleoside diphosphates (dNDPs) 
(Holmgren et al., 1965; Reichard et al., 1961; Thelander and Reichard, 1979). The dNDPs are 
subsequently phosphorylated to the triphosphate state for use by DNA polymerase. In 
eukaryotes, although genomic replication is nuclear, RNR and dNTP biosynthesis occurs in 
the cytosol. dNTP pools in replicating cells are at a low steady-state concentration and are 
rapidly turned-over, indicating that the precursors are polymerized into DNA almost 
immediately upon their production (Rottgen and Rabes, 1989). Indeed, cellular DNA 
precursor pools, even during S phase, are typically only a small fraction of the concentration 
of RNA precursor pools (Rottgen and Rabes, 1989; Spyrou and Holmgren, 1996). Consistent 
with this, RNR shows tight product- and substrate-mediated allosteric regulation, in 
particular in response to local concentrations of dATP (Holmgren, 1981; Holmgren et al., 
1965; Reichard et al., 2000). This feedback regulation is thought to be critical for maintaining 
replication fidelity and preserving genome-integrity. Thus, replication accuracy by DNA 
polymerase is optimal only within a narrow window of concentrations for each dNTP; 
treatments that skew normal dNTP pools have been shown to be either mutagenic or pro-
apoptotic in different systems (Kunkel et al., 1982; Nicander and Reichard, 1983; Oliver et 
al., 1996). 
Although three different classes of RNR enzymes are known to exist across the different 
biological kingdoms, all of these enzymes require a source of electrons and a metal co-factor, 
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and all proceed by a reaction that involves a free radical intermediate (Atkin et al., 1973; 
Holmgren and Sengupta, 2010; Thelander and Reichard, 1979). Classes II and III are found 
only in a restricted subset of anaerobic or otherwise specialized microbes. These enzymes 
were discussed in detail in a recent review (Holmgren and Sengupta, 2010) and will not be 
considered further here. The most common class, class I, is found in eukaryotes and in most 
aerobic prokaryotes (Torrents et al., 2006). These enzymes are composed of two subunits: 
the B1 and B2 proteins in bacteria, or the functionally similar R1 and R2 proteins (also called 
M1 and M2) in eukaryotes (Brown et al., 1969; Thelander and Reichard, 1979). The B1 or R1 
protein possesses the catalytic site for reduction of all four rNDPs, whereas the B2 or R2 
subunit contains the protein-tyrosyl radical (Akerblom et al., 1981; Avval and Holmgren, 
2009). Every cycle of nucleotide reduction results in generation of disulfide in the C-
terminus of the B1 or R1 subunit, which must be reduced to a dithiol for the next reductive 
cycle (Avval and Holmgren, 2009). 
 
 
 
 
Fig. 2. Sources of DNA precursors. RNR is the key player on the de novo dNTP biosynthesis 
pathway, in which rNDPs are converted to dNDPs in eukaryotes and most prokaryotes. In 
addition to rNDPs, RNR requires a source of electrons as reducing potential (green arrow, 
see text). Arrow weight is diagrammatic of relative flux or activity of each step. The drug 
hydroxyurea (HU) scavenges the tyrosyl protein-free radical in RNR, thereby blocking RNR 
activity (red). Below is the salvage pathway, in which exogenous deoxyribonucleosides are 
assimilated by outer membrane transporters and kinased to form dNTPs. BrdU (blue) is 
incorporated via the salvage pathway, which, although it cannot generally support S phase 
replication (see text), does contribute sufficient DNA precursors to genome replication that 
BrdU will label all S phase (replicating) cells (Arner and Eriksson, 1995; Thelander and 
Reichard, 1979; Yarbro, 1992).  
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Mammalian cells have two distinct RNR enzymess that both share a common catalytic R1 
subunit, but differ in their second subunit, with one isoform being S phase-specific and 
containing R2 protein and the other being expressed throughout the cell cycle as well as in 
post-replicative cells and having a distinct protein, p53R2, as the second subunit (Avval and 
Holmgren, 2009; Holmgren and Sengupta, 2010; Pontarin et al., 2007). The R1/R2 protein 
drives S phase genome replication; the R1/p53R2 protein is thought to play a major role in 
providing dNTPs for mitochondrial DNA replication and repair (Pontarin et al., 2007). 
In addition to an obvious requirement for rNDPs, RNR requires a source of reducing 
potential or, more specifically, electrons, to restore the dithiol state of the B1 or R1 C-
terminal disulfide after each catalytic cycle (Fig. 3) (Holmgren and Sengupta, 2010). The 
common distal source of this reducing potential is NADPH. In eubacteria, electrons can flow 
to RNR from NADPH by either a TrxR- or a Gsr-dependent route (Fernandes and 
Holmgren, 2004; Gleason and Holmgren, 1988; Holmgren, 1976; Holmgren, 1981; Holmgren, 
1989; Laurent et al., 1964; Lillig and Holmgren, 2007). In the TrxR-dependent route, TrxR 
uses electrons from NADPH + H+ to reduce oxidized (disulfide) Trx to the reduced (dithiol) 
form, while generating NADP+ (Arner, 2009; Arner and Holmgren, 2000). Reduced Txn, 
then, can directly restore the active reduced state of RNR (Avval and Holmgren, 2009; 
Laurent et al., 1964). In the Gsr-dependent route, electrons extracted from NADPH + H+ are 
used by Gsr to reduce oxidized di-glutathione (GSSG) to the reduced monomeric state 
(GSH), again yielding NADP+ (Fernandes and Holmgren, 2004; Holmgren, 2000). Whereas 
GSH has numerous activities in cells (Fernandes and Holmgren, 2004), one of these is to 
restore oxidized (disulfide) Grxs to the reduced state (dithiol-Grx), which like reduced Trx, 
can restore the reduced active state of RNR (Avval and Holmgren, 2009; Holmgren, 1976; 
Holmgren, 1977; Holmgren, 1978; Holmgren, 1979; Luthman et al., 1979) (Fig. 3). 
 
 
Fig. 3. Sources of electrons for RNR. Either the Trx cycle (blue) or the GSH cycle (green) can 
support reduction of ribonucleotides by RNR. The Trx cycle is summarized in Fig. 2. In the 
GSH cycle, Gsr uses reducing potential from NADPH  to reduce one mole of oxidized di-
glutathione (GSSG) to 2 moles of reduced glutathione (GSH). GSH has many roles in cells, 
one of which is to restore the reduced state of oxidized Grx. Reduced Grx, then, can serve as 
a proximal electron donor for RNR (Holmgren and Sengupta, 2010). 
4. Contributions of the GSH and Trx pathways in supporting RNR 
Although growth differences have not been reported between E. coli having only a GSH- or 
only a Trx-pathway (Holmgren, 1977; Holmgren, 1979), catalytically Grx is the most efficient 
www.intechopen.com
 
DNA Replication - Current Advances 
 
570 
electron donor for the reaction (Gon et al., 2006). By contrast, yeast and plants deficient in 
TrxRs show slow-growth phenotypes (Koc et al., 2006; Reichheld et al., 2007; Sweat and 
Wolpert, 2007), suggesting Gsr-dependent routes are poor at supporting DNA replication in 
these eukaryotes. It was anticipated that all eukaryotic systems might depend primarily on 
the Trx system to supply electrons to RNR for DNA replication. Consistent with this, mice 
homozygous for a spontaneous null mutation of the gsr gene showed no defects in growth 
or DNA replication (Rogers et al., 2004), and mice zygotically homozygous-null for either 
the txn1 gene encoding cytosolic Trx1 (Matsui et al., 1996) or the txnrd1 gene encoding 
cytosolic TrxR1 (Bondareva et al., 2007; Jakupoglu et al., 2005), are both embryonic-lethal. 
From these findings, it was inferred that, in mice under normal conditions, the GSH 
pathway may be superfluous for replication, yet the cytosolic Trx pathway is critical 
(Jakupoglu et al., 2005). However, since none of the studies on components of the cytosolic 
Trx systems directly showed that these mutations blocked DNA replication, per se, 
alternative explanations for embryonic lethality were not ruled out. Indeed, in reporting our 
study, we argued that the degree of cell proliferation seen prior to embryonic loss in TrxR1-
deficient embryos was inconsistent with a block to proliferation, and instead suggested that 
the pre-resorption phenotype of TrxR1-deficient embryos was more consistent with an 
embryonic patterning defect (Bondareva et al., 2007)(see below). 
5. Evolution of the TrxR protein families 
GSH- and Trx-pathways are each ubiquitous in biology (Fig. 4). With the advent of 
organellar compartmentalization in early eukaryotes, it likely became important for cells to 
ensure an adequate level of activity for each pathway both in the cytosol as well as within 
the often relatively impervious confines of the organelles. For most components of these 
pathways in most eukaryotic systems, such as Grxs, Trxs, and TrxRs, separate genes arose 
by gene duplication that evolved to specialize, albeit to varying extents, in production of 
either cytosolic or mitochondrial isoforms of these enzymes (Gleason and Holmgren, 1981; 
Meyer et al., 2009; Meyer et al., 2008; Novoselov and Gladyshev, 2003; Sandalova et al., 2001; 
Taskov et al., 2005; Williams et al., 2000). For other components of these pathways, however, 
such as Gsr, cytosolic and mitochondrial functions are generally accomplished by 
expressing both cytosol- and mitochondria-targeted versions of the protein from a single 
gene. In an extreme example, the parasitic tapeworm Echinococcus has a single gene that 
issues the enzyme responsible for reduction of both Txr and GSSG in both the cytosol and 
the mitochondria (Bonilla et al., 2008) (see below).  
Despite the ubiquity of these systems in the living world, TrxR enzymes underwent a 
striking evolutionary transition that sets it apart from other components in these systems 
(Zhong et al., 1998). Thus, whereas all Gsrs are homologous, all Grxs are homologous, and 
all Trxs are homologous, TrxRs are diphyletic, being represented by two distinct protein 
families (Arner, 2009; Arner and Holmgren, 2000; Sandalova et al., 2001). The more ancient 
family, here called the “E. coli-type TrxRs” for the species it was first described from (Moore 
et al., 1964), is found in all eubacteria, archaea, fungi, most protists, and most plants and 
algae (Fig. 4., shaded light blue). Metazoan animals universally share a distinct family of 
TrxR proteins (“metazoan-TrxRs”; shaded red in Fig. 4) (Arner, 2009; Arscott et al., 1997; 
Eckenroth et al., 2006; Novoselov and Gladyshev, 2003; Williams et al., 2000; Zhong et al., 
1998).  
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Fig. 4. Distribution of TrxR families in living kingdoms. E. coli-type TrxRs (blue) are found 
in most extant life forms, with the exception of metazoans (red), one green algae, and a few 
parasitic protists (red dots), which have metazoan-type TrxRs (Novoselov and Gladyshev, 
2003). Thus, the metazoan-type TrxRs appeared before separation of ancestral metazoans 
onto a distinct lineage and was retained in a subset of plants and algae and in a subset of 
protists (Novoselov and Gladyshev, 2003) (fine red lines). See text for more details. 
Evolution of the metazoan TrxR appears to have been brought about by extension of the C-
terminal protein coding sequences of the gsh gene, leading to acquisition of the new C-
terminal active site (Novoselov and Gladyshev, 2003). In this enzyme, the C-terminal active 
site, which directly reduces oxidized Trx, generally but not always contains the atypical 21st 
amino acid selenocysteine (Sec) translationally inserted in the penultimate position (Arner, 
2009; Hondal and Ruggles, 2010; Lu and Holmgren, 2009). This overall design gives the 
impression of an enzyme that was built by “retrofitting” a new C-terminal active site onto 
an existing NADPH-dependent reductase (Schmidt and Davies, 2007), either by classical 
exon shuffling (Margulies and McCluskey, 1985) or by mutation of the stop codon and 
translational read-through into previously 3’-untranslated sequences (Novoselov and 
Gladyshev, 2003).  
It is unclear why an ancestor to all extant metazoans eventually discarded its E. coli-type 
TrxRs, which presumably functioned adequately in its ancestors and continues to do so for 
nearly all contemporary non-metazoans within all biological kingdoms (Fig. 4). From the 
perspective of the nominal reaction catalyzed by TrxRs in either E. coli or mammalian 
systems, neither the distal source of electrons (NADPH) nor the substrate (oxidized Trx) 
differs. However, the E. coli and metazoan enzymes are not equivalent, and this 
evolutionary enzyme-exchange was unlikely to be selectively “neutral”. Key differences 
between the two enzyme families are that the E. coli-type enzymes are smaller (~35 kDa) and 
highly specific for reduction of oxidized Trx, whereas metazoan TrxRs are larger proteins 
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(~55 kDa) that evolved from Gsr and are capable of reducing a broad range of substrates 
(Arner, 2009; Arscott et al., 1997; Holmgren and Bjornstedt, 1995; Lu and Holmgren, 2009; 
Williams et al., 2000). Although they evolved from Gsr and have a broad substrate 
specificity, the classical mammalian TrxR1 and TrxR2 enzymes do not reduce GSSG (Sun et 
al., 2001). However, the testis-specific mammalian TrxR3 protein, also called thioredoxin-
glutathione reductase or TGR, as well as the Sec-lacking TrxR protein in Drosophila, does 
reduce GSSG (Gromer et al., 2003; Johansson et al., 2006; Sun et al., 2001; Sun et al., 2005), 
and in some lower metazoans such as Echinococcus, a single gene, within the metazoan TrxR 
family and containing Sec in its C-terminal active site, encodes all known Trx- and GSSG-
reductase activities (Bonilla et al., 2008). One might hypothesize that, by exchanging the 
ancestral E. coli-type TrxR enzymes for the metazoan version, the evolutionary capacity of 
the lineage might have been potentiated; however since both enzymes will effectively 
reduce Trx, this model suggests the evolutionary advantage of the new enzyme for 
metazoans is related to other activities that differ between these enzyme types (Arner and 
Holmgren, 2000; Arner et al., 1996; Lothrop et al., 2009). Alternatively, one might imagine 
that, if an ancestral metazoan evolved a TGR enzyme that could replace both the ancestral 
TrxR and Gsr activities, as the Echinococcus version does, then perhaps the ancestral E. coli-
type TrxR and the ancestral Gsr were simply and irrevocably lost as being redundant with 
the new bi-functional TGR enzyme, as seen in Echinococcus. Subsequent specialization could 
have led to a gene-duplication of TGR and loss of the C-terminal TrxR-specific domain in 
one of the duplicates, essentially reverting one copy of the gene to a classical Gsr protein 
that is still recognized as homologous to the ancestral version.  
Interestingly, a few unicellular eukaryotes do contain “metazoan-type” TrxR enzymes 
(Novoselov and Gladyshev, 2003)(Fig. 4, red “dots” at top of “Plant and algae” and “Protist” 
branches of the tree). These include both a small number of protozoan parasites and a single 
known green alga (Holmgren and Lu, 2010; Novoselov and Gladyshev, 2003). In at least one 
case (the photosynthetic alga Chlamydomonas), both E. coli- type and metazoan-type TrxRs 
are found in the same genome (Novoselov and Gladyshev, 2003). Thus, there is a precedent 
for co-existence of both enzyme types in a single genome. One model to explain this odd 
disribution of the metazoan-type TrxR would be that these few non-metazoan species 
acquired the metazoan-type TrxR proteins by lateral gene transfer. Indeed, this hypothesis 
was raised previously when this isoform was discovered in members of genus Plasmodium, 
the malaria-causing parasites, and in other related protozoan parasites (Hirt et al., 2002; 
Rahlfs et al., 2002; Williams et al., 2000). Based both on the oddity of non-metazoans having 
this isoform and the intimate intracellular interaction between these intracellular protozoan 
parasites and both their vertebrate and invertebrate metazoan hosts, lateral gene transfer 
from host to parasite seemed a plausible model for the appearance of this unexpected 
isoform outside of metazoans. However, the subsequent discovery of a metazoan-type 
TrxR1 in Chlamydomonas, along with the absence of other signatures of lateral gene transfer 
between metazoans and the few single-cell eukaryotes that have this isoform, suggest lateral 
gene transfer is, in this case, an unlikely model (Novoselov and Gladyshev, 2003). Instead, 
the most parsimonious model of ancestry of the metazoan-type TrxRs is that the protein 
evolved only once by C-terminal extension of a copy of the gsr gene in a pre-metazoan 
ancestor; although lineages bearing this enzyme persisted to modern times in all metazoans 
as well as in a very small subset of algae and parasitic protozoa (Fig. 4, fine red lines) 
(Novoselov and Gladyshev, 2003).  
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6. Requirements of disulfide reductases for replication in rodent models 
Early studies showed that some mammalian Grxs could reduce mammalian RNR in vitro 
(Luthman et al., 1979; Luthman and Holmgren, 1982), and that Trx generally did not co-
localize to cells expressing the S phase-specific R1 subunit of RNR in rat tissues, suggesting 
that Trx is not the major physiological electron donor for RNR (Hansson et al., 1986). 
However experimentally, animal systems deficient in the Trx pathway were slow to appear. 
RNAi “knock-down” studies on mammalian cell cultures suggested replication was not 
impaired by ablation of TrxR1 (Yoo et al., 2006; Yoo et al., 2007); however questions of 
residual pre-formed TrxR1 protein in these systems lingered. The first studies on mouse 
knock-out models having homozygous zygotic disruption of the txnrd1 gene, which encodes 
TrxR1, showed evidence of active and extensive proliferation prior to embryonic lethality 
(Bondareva et al., 2007; Jakupoglu et al., 2005). Because TrxR1-deficient embryos 
accumulated several thousand cells, it was unlikely that residual maternal TrxR1 had driven 
the replication cycles. More recently, by using conditional disruption of the txnrd1 gene in 
mouse livers, my group has been able to provide a more detailed examination of the roles of 
TrxR1 for replication in animal cells (Rollins et al., 2010; Suvorova et al., 2009). During liver 
development and regeneration, normal mice and mice having TrxR1-deficient hepatocytes 
exhibit similar liver growth rates and similar levels of proliferative, S, and M phase 
hepatocytes. Regenerative thymidine incorporation is similar in normal and TrxR1-deficient 
livers, further indicating that DNA synthesis is unaffected (Rollins et al., 2010). The use of 
genetic chimeras in which a fluorescently marked subset of hepatocytes was TrxR1-deficient 
while others were not, revealed that the multigenerational contributions of both normal and 
Txnrd1-deficient hepatocytes to development and to liver regeneration were 
indistinguishable (Rollins et al., 2010). Thus, TrxR1 is truly superfluous for DNA replication 
and RNR activity in otherwise normal mouse hepatocytes. 
Questions remain as to whether TrxR1-independent replication will prove to be a general 
phenomenon of mammalian cells or a peculiarity of hepatocytes. Both primary papers on 
mouse embryos lacking TrxR1 reported that it proved impossible to establish cultures of 
primary fibroblasts from mutant embryos; however it was not established whether this 
failure resulted from a block to replication or some other defect (Bondareva et al., 2007; 
Jakupoglu et al., 2005). As time passes, more and more cell types are being found to replicate 
in the absence of TrxR1. Recently, it was shown that lymphomas lacking TrxR1 can initiate 
and progress normally in mice (Mandal et al., 2010), adding another cell type to the list of 
cell types that can replicate in the absence of TrxR1. Also, in investigations using a 
fluorescent marker-tagged system in which both copies of the TrxR1 gene were disrupted in 
an arbitrary population of all cell types in fetal mice, my group assessed which, if any, cell 
types failed to contribute to the adult mouse two months later. No cell types could be 
identified that did not still contribute to the adult mouse under these conditions (CM 
Weisend and EE Schmidt, unpublished). Thus, whereas we cannot exclude the possibility 
that there could be some rare cell types in mice in which replication is critically dependent 
on TrxR1, our efforts to date have failed to pinpoint any such cell types. 
Recently, a study was reported on disruption of TrxR1 in another metazoan, the nematode C. 
elegans (Stenvall et al., 2011). C. elegans has only a single TrxR protein, and this is the only Sec-
containing protein in the worm genome (Stenvall et al., 2011). Surprisingly, although worms 
lacking TrxR1 show a molting defect due to an inability to reduce protein disulfides in the old 
cuticle to allow its removal, but like mouse livers lacking TrxR1 (Rollins et al., 2010; Suvorova 
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et al., 2009), they show no evidence of oxidative stress or replicative insufficiency (Stenvall et 
al., 2011). Like in mice (Rollins et al., 2010), the source of electrons for RNR in worms remains 
unclear and will likely be an important subject for future investigation. 
7. Alternative pathways of supplying electrons to RNR 
Mammalian genomes contain three different genes encoding thioredoxin reductases. The 
txnrd1 gene encodes TrxR1, the cytosolic enzyme; txnrd2 encodes TrxR2 (also called Txnrd2 or 
TR3), the mitochondrial enzyme; and txnrd3 encodes TrxR3 (also called Txnrd3, TGR, or TR2), 
a testis-specific cytosolic enzyme that can reduce either Trx1 or GSSG (Arner, 2009; 
Gerashchenko et al., 2010; Su et al., 2005). In most normal rodent tissues with the exception of 
testis, TrxR1 mRNA is about five-fold more abundant than TrxR2 mRNA, and TrxR3 mRNA is 
undetectable (Jurado et al., 2003). Previously, we have shown that neither TrxR2 mRNA nor 
TrxR3 mRNA are induced in TrxR1-deficient embryos (Bondareva et al., 2007) or livers 
(Suvorova et al., 2009), indicating that there is not an induction of the genes encoding either of 
the other known TrxRs that might compensate for ablation of TrxR1. However, it remained 
possible that normal levels of TrxR2 protein, though perhaps lower than normal levels of 
TrxR1 protein (see above), might be sufficient to compensate for loss of TrxR1 without an 
associated increase in mRNA levels. It is well established that the cytosolic and mitochondrial 
TrxR enzymes in Arabidopsis are cross-complementary. Thus, disruption of the gene encoding 
either of these E. coli-type TrxRs is compensated by a partial re-distribution of product from 
the other gene into the deficient sub-cellular compartment (Meyer et al., 2008; Reichheld et al., 
2007; Sweat and Wolpert, 2007). To date, there is no in vivo evidence of similar cross-
complementation occurring in mammalian systems. Nevertheless, several ESTs issued from 
the txnrd2 gene but lacking the N-terminal mitochondrial transit signal have been reported 
from mammalian systems, which suggests the possibility that the txnrd2 gene could yield 
cytosolic isoforms of TrxR2 (Turanov et al., 2006). Closer examination of this possibility will be 
important for determining whether cytosolic isoforms of TrxR2 participate in replication or 
homeostatic maintenance of mammalian cells lacking TrxR1. 
Another system that might be compensating for loss of TrxR1 and supporting RNR activity 
and DNA replication in TrxR1-deficient hepatocytes is the GSH system. Neither livers nor 
embryos lacking TrxR1 exhibit compensatory induction of Gsr; however they do exhibit 
induction of mRNA encoding the modifier subunit of glutamate-cysteine ligase (Gclm), the 
rate limiting enzyme in GSH biosynthesis (Bondareva et al., 2007; Suvorova et al., 2009). A 
recent study showed that the GSH pathway, reconstituted entirely from recombinant or 
purified components (Gsr, GSH, and Grx), can effectively transfer electrons from NADPH to 
RNR and drive reduction of ribonucleoside diphosphates in vitro (Avval and Holmgren, 
2009). In combination with the classical study showing that S-phase cells in normal rat 
tissues did not tend to exhibit Txr immunostaining (Hansson et al., 1986), there is a good 
possibility that the GSH system is supporting RNR activity in TrxR1-deficient hepatocytes 
(Holmgren and Sengupta, 2010); however other possibilities still exist, and all of these will 
need to be tested in vivo.  
8. Considerations beyond supplying electrons to RNR 
Decades of elegant studies on microbial and other non-metazoan systems revealed that, 
typically, if inhibition of disulfide reductases disrupted the supply of electrons to RNR, 
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growth was abated; if not, growth was overtly normal (Gleason and Holmgren, 1988; 
Holmgren, 1985). In some cases, disruption of the Trx system was reported to yield 
intermediate growth phenotypes in non-metazoan eukaryotic systems (Koc et al., 2006; 
Meyer et al., 2009; Meyer et al., 2008; Reichheld et al., 2007; Sweat and Wolpert, 2007), 
apparently due to compromised output by RNR (Koc et al., 2006). Some studies on microbial 
models have shown that disruption of the Trx system can independently cause a disruption 
in homeostatic redox control or stress responses (Arner and Holmgren, 2000; Carmel-Harel 
et al., 2001; Carmel-Harel and Storz, 2000; Holmgren, 2000). Also, in mammalian systems, an 
intimate connection between intracellular signaling by the platelet-derived growth factor 
receptor (PDGFR), the T cell receptor, the epidermal growth factor receptor (EGFR), the 
tumor necrosis factor-α receptor (TNFAR), and likely other related phosphotyrosine 
receptors and Prxs has been established (Bae et al., 1997; Choi et al., 2005; Devadas et al., 
2002; Kang et al., 1998; Rhee, 1999; Rhee et al., 2000), thereby indirectly linking the Trx 
pathway with physiological growth factor signaling. Thus, it is important to bear in mind 
that disruptions of cell physiology in response to perturbations in the Trx or GSH pathways, 
in particular in whole animals or other complex systems, is not necessarily indicative of a 
replicative block, and these distinctions can sometimes be difficult to tease apart 
experimentally.  
A case in point is the as yet mechanistically uncertain causes of embryonic lethality in 
TrxR1-deficient mice (Bondareva et al., 2007; Jakupoglu et al., 2005). My group and that of 
Dr. Markus Conrad each generated independent and strategically distinct conditional-
mutant alleles of the txnrd1 gene that, in the zygotically homozygous-mutant state, result in 
embryonic lethality (Bondareva et al., 2007; Jakupoglu et al., 2005). In each case, the 
homozygous-mutant zygote proliferates to yield thousands of TrxR1-deficient cells prior to 
embryonic failure. Subsequently, using regulated disruption of these conditional alleles, 
mouse cells homozygous null for either allele have been shown to replicate vigorously 
(Mandal et al., 2010; Rollins et al., 2010), suggesting proliferation is normal in TrxR1-
deficient cells. Why, then, do the mutant embryos die?   
Although the reported details of embryonic progression differ between the two alleles, the 
system developed in my lab, with which I am most familiar, shows a phenotype that I 
believe lends clues to the answer. Despite the mutant embryos surviving and proliferating 
to embryonic day 8.5 (E8.5), the embryos become phenotypically abnormal much earlier 
(Bondareva et al., 2007). During post-blastocyst development, we detect no evidence of node 
formation, no development of primitive streak, and no differentiation of mesoderm 
(Bondareva et al., 2007). As a result, no body axis forms, normal patterning is not 
established, and the TrxR1-deficeint embryonic cells proliferate as a disorganized mass of 
primitive endoderm and ectoderm until, by E8.5, they have likely exceeded the volumetric 
constraints for survival without a functional (mesoderm-derived) cardiovascular and 
hematopoietic system. At this point, the embryo likely becomes necrotic and is simply 
resorbed by the mother (Bondareva et al., 2007). This phenotype is consistent with failure of 
early morphogen-signaling events. To date, we have not entirely ruled-out a possible 
proliferative defect in some unidentified early embryonic cell type as underlying embryonic 
lethality. Indeed, the recently reported metabolic eccentricities of mouse embryonic stem 
cells for replication (Wang et al., 2009) might suggest one rare but critical cell type that 
needs TrxR1 activity for full replicative potential, and whose perturbation might disrupt 
formation of node, primitive streak, and mesoderm. Further investigations will be required 
to test this possibility. However, the proliferative characteristics of the TrxR1-deficient 
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mouse cells that have been studied to date disfavor this model (Mandal et al., 2010; Rollins 
et al., 2010). Conversely, the known interdependence of growth factor signaling on the Trx 
pathway (Choi et al., 2005; Rhee et al., 2005) is consistent with this embryonic phenotype. It 
is anticipated that these possibilities will be resolved in the very near future. 
9. Summary and implications 
Genome replication in most living systems is critically dependent on the activity of RNR. 
DNA synthesis is fairly rare in healthy adult mammals, being restricted to repair, 
mitochondrial renewal, and genome replication for a small subset of cells, including 
immune cells, germ cells, cells of the hair follicles, some intestinal epithelial cells, and a few 
others. However, certain diseases, such as cancers and some viral diseases, are critically 
dependent on DNA replication, and therefore are frequently combated with drugs that 
block this process. The key dependence of replication on RNR has made RNR an important 
drug-target for cancer and viral chemotherapies. Indeed, the classic chemotherapeutic drug 
HU directly inhibits RNR (Hatse et al., 1999; Lori and Lisziewicz, 1998; Newton, 2007; 
Romanelli et al., 1999; Szekeres et al., 1997; Yarbro, 1992), and various newer 
chemotherapeutics function similarly (Mayhew et al., 2002; Mayhew et al., 2005; Smart, 
1995; Szekeres et al., 1994; Tsimberidou et al., 2002). Unfortunately, as with many 
chemotherapeutics, intra-host evolution of drug resistance by the diseased tissue is a 
common problem (Akerblom et al., 1981; Balzarini, 2000; Wright et al., 1990). The absolute 
dependency of RNR on a suitable electron-donor system has long suggested alternative 
mechanisms for blocking RNR activity, in particular in cases of HU resistance. Drugs that 
target either the Trx pathway, such as aurothioglucose, or the GSH pathway, such as 
buthionine sulfoxamine (BSO) have been developed and are well tolerated (Arner and 
Holmgren, 2000; Arner and Holmgren, 2006; Griffith and Meister, 1985; Lu et al., 2007; 
Williamson et al., 1982). Recent whole animal genetic studies reviewed here, however, 
suggest that in many if not all mammalian cells, either the GSH or the Trx pathway alone 
might be robust at supporting S phase RNR activity in the absence of the other. Thus, 
chemotherapeutic approaches to blocking DNA replication through disruption of disulfide 
reductase pathways will need to be cognizant of the potentially complete functional 
redundancy of the GSH and Trx pathways in animal systems, and sensitive to the various 
other physiological roles these pathways play in normal homeostatic and stress-response 
pathways.  
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